Rodica Pop-Busui, MD, PhD, is a prominent diabetologist at the University of Michigan in Ann Arbor, and a nationally and internationally recognized leader in the field of diabetes as a result of her extensive clinical, research, teaching, and service activities. Dr. Pop-Busui is the site Principal Investigator and member of the Steering Committee of the newly funded NIDDK trial "PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in Type 1 Diabetes" and site Principal Investigator in the NIDDK-funded trial "Glycemia Reduction Approaches for Diabetes: A Comparative Effectiveness Study (GRADE)." Dr. Pop-Busui has received awards from the Fulbright Foundation, the American Diabetes Association, and the University of Michigan.
